Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
FULC
#4057
Fulcrum Therapeutics, Inc. Common Stock
8.3
8
-3.68%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-3.68%
Monthly Change
-23.26%
6 month change
+25.26%
Cambio anual
+145.75%
Cierres anteriores
8.7
0
Open
8.3
8
Bid
Ask
Low
8.3
8
High
8.3
8
Volumen
82
Markets
Acciones
Atención Sanitaria
FULC
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
32.67 M
40.64 M
61.76 M
61.94 M
53.98 M
66.6 M
—
Valuation ratios
Enterprise value
325.54 M
683.46 M
452.8 M
420.99 M
195.49 M
555.72 M
1.45 B
Price to earnings ratio
—
—
-3.24
-4.53
-29.38
-9.58
-4.91
Price to sales ratio
—
—
0.06
0.16
0
—
—
Price to cash flow ratio
—
—
0
0
0.13
0.01
-0.06
Price to book ratio
—
—
0
0
0
0
0.01
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.55
0.34
0.48
0.38
0.04
0.2
0.3
Return on equity %
0.74
0.38
0.55
0.41
0.04
0.21
0.31
Return on invested capital %
694.39
255.15
242.06
217.3
41.52
188.47
—
Gross margin %
100
100
100
100
100
—
—
Operating margin %
811.64
422.97
1 774.85
3 945.24
27.37
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
802.66
421.89
1 732.43
3 470.05
12.16
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
4.47
11.77
12.41
17.71
22.63
27.4
98.22
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.07
0.11
0.03
0.01
0.31
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
2 157.1
1 483.69
35.78
948.07
270.23
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
780.11
416.95
939.15
3 117.88
3 133.39
Net current asset value per share
—
—
4 612.46
3 950.4
4 032.06
5 642.49
5 719.88
Tangible book value per share
—
—
4 421.82
3 836.13
3 920.92
5 508.64
15.76 K
Working capital per share
—
—
4 240.71
3 727.35
3 853.88
5 436.54
5 510.55
Book value per share
—
—
4 421.82
3 836.13
3 920.92
5 508.64
5 584.08
Noticias
Fulcrum: Strong HbF Signal, Narrow TAM, Same 'Hold' Conclusion (NASDAQ:FULC)
Las acciones de Fulcrum Therapeutics caen tras fallar el ensayo de células falciformes
Acciones de Fulcrum Therapeutics caen tras fallar ensayo de células falciformes
Fulcrum Therapeutics stock falls as sickle cell trial misses target
Leerink reitera calificación de acciones de Fulcrum Therapeutics tras datos de ECF
Leerink reitera calificación de Fulcrum Therapeutics tras datos de SCD
Leerink reiterates Fulcrum Therapeutics stock rating on SCD data
BofA reitera calificación de Bajo Rendimiento para Fulcrum Therapeutics en 7 dólares
BofA reitera calificación Underperform para Fulcrum Therapeutics en $7
BofA reiterates Fulcrum Therapeutics stock Underperform rating at $7
Stifel reitera calificación de acciones de Fulcrum Therapeutics tras datos del fármaco
Stifel reitera calificación de Fulcrum Therapeutics tras datos del fármaco